Enanta Pharmaceuticals
ENTA
ENTA
180 hedge funds and large institutions have $917M invested in Enanta Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 64 increasing their positions, 53 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
1% less capital invested
Capital invested by funds: $928M → $917M (-$11.2M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
85% less call options, than puts
Call options by funds: $269K | Put options by funds: $1.77M
Holders
180
Holding in Top 10
1
Calls
$269K
Puts
$1.77M
Top Buyers
| 1 | +$17.6M | |
| 2 | +$9.96M | |
| 3 | +$7.59M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$4.69M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.49M |
Top Sellers
| 1 | -$12.3M | |
| 2 | -$6.65M | |
| 3 | -$6.05M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$6.03M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$6.03M |